Chase AIPricingFAQs
Display currency
Loading news…

DeCODE Genetics

Reykjavík, Gullbringusysla, Iceland

DeCODE Genetics is a biopharmaceutical company that develops and offers diagnostic tests for variants in genes.

DeCODE Genetics was acquired by Amgen in 2012 for $415M.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
1
Monthly Visits
Available in Pro
Contacts
41

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Company Info

Org types
company
HQ
Reykjavík, Gullbringusysla, Iceland

Acquisitions by DeCODE Genetics

Loading columns…
0 of 0Show
Page 1 / 1

Key People at DeCODE Genetics

Founder and CEO
Vice President of Research
Vice President of Statistics
Vice President of Informatics
41
professional contacts at DeCODE Genetics
Contact execs at DeCODE Genetics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to DeCODE Genetics

Loading news…

FAQs about DeCODE Genetics

People who checked this page also checked these

Sectors DeCODE Genetics invests & acquires in

M&A by year

Browse the full Acquirezy directory.
DeCODE Genetics - Company Profile, Full Acquisitions List, Funding and Investments